The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases.
Open accessAbstract
The success of solid tumor growth and metastasis is dependent upon angiogenesis. Neovascularization within the tumor is regulated, in part, by a dual and opposing system of angiogenic and angiostatic factors. We now report that IP-10, a recently described angiostatic factor, as a potent angiostatic factor that regulates non-small cell lung cancer (NSCLC)-derived angiogenesis, tumor growth, and spontaneous metastasis. We initially found significantly elevated levels of IP-10 in freshly isolated human NSCLC samples of squamous cell carcinoma (SCCA). In contrast, levels of IP-10 were equivalent in either normal lung tissue or adenocarcinoma specimens. The neoplastic cells in specimens of SCCA were the predominant cells that appeared to express IP-10 by immunolocalization. Neutralization of IP-10 in SCCA tumor specimens resulted in enhanced tumor-derived angiogenic activity. Using a model of human NSCLC tumorigenesis in SCID mice, we found that NSCLC tumor growth was inversely correlated with levels of plasma or tumor-associated IP-10. IP-10 in vitro functioned as neither an autocrine growth factor nor as an inhibitor of proliferation of the NSCLC cell lines. Reconstitution of intratumor IP-10 for a period of 8 wk resulted in a significant inhibition of tumor growth, tumor-associated angiogenic activity and neovascularization, and spontaneous lung metastases, whereas, neutralization of IP-10 for 10 wk augmented tumor growth. These findings support the notion that tumor-derived IP-10 is an important endogenous angiostatic factor in NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Clinical Applications of Research on Angiogenesis
Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,264
Interleukin-8 as a macrophage-derived mediator of angiogenesis
Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., & Strieter, R. M. (1992) · Science · doi:10.1126/science.1281554 · Cited by 2,135 · cited 1×
“In contrast, C X C chemokines that contain the ELR motif, such as interleukin-8 (IL-8), neutrophil activating protein-2 (NAP-2), growth-related oncogene alpha (GRO-o 0, GRO-[3, G R O - y , epithelial neutrophil activating protein-78 (ENA78), and granulocyte chemotactic protein-2 (GCP-2), induce angiogenic activity at…”
Self-citationProperties Of The Novel Proinflammatory Supergene Intercrine Cytokine Family
Oppenheim, J. (1991) · Annual Review of Immunology · doi:10.1146/annurev.immunol.9.1.617 · Cited by 1,877
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222 · cited 4×
“For example, platelet factor-4 (PF-4), monokine induced by interferon-gamma (MIG), and IP-10 all lack the ELR motif and are angiostatic factors (25, 39, 40).”
InfluentialSelf-citationGood, D. J., Polverini, P. J., Rastinejad, F., Le Beau, M. M., Lemons, R. S., Frazier, W. A., & Bouck, N. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6624 · Cited by 1,054
Self-citationLuster, A. D., Unkeless, J. C., & Ravetch, J. V. (1985) · Nature · doi:10.1038/315672a0 · Cited by 944
TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION
Gimbrone, M. A., Leapman, S. B., Cotran, R. S., & Folkman, J. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.2.261 · Cited by 903
Activated macrophages induce vascular proliferation
POLVERINI, P. J., COTRAN, R. S., GIMBRONE, M. A., & UNANUE, E. R. (1977) · Nature · doi:10.1038/269804a0 · Cited by 810
Self-citationBiology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines.
Miller, M. D., & Krangel, M. S. (1992) · PubMed · Cited by 731
Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.
Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. M., Maheshwari, S., Kleinman, H. K., Reaman, G. H., & Tosato, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.155 · Cited by 705
Self-citationInhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides
Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., & Sharpe, R. J. (1990) · Science · doi:10.1126/science.1688470 · Cited by 697
Standiford, T. J., Kunkel, S. L., Basha, M. A., Chensue, S. W., Lynch, J. P., Toews, G. B., Westwick, J., & Strieter, R. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114928 · Cited by 687
Self-citationPober, J. S., Gimbrone, M. A., Cotran, R. S., Reiss, C. S., Burakoff, S. J., Fiers, W., & Ault, K. A. (1983) · The Journal of experimental medicine · doi:10.1084/jem.157.4.1339 · Cited by 628
Sidky, Y. A., & Borden, E. C. (1987) · PubMed · Cited by 494
Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene
Rastinejad, F., Polverini, P. J., & Bouck, N. P. (1989) · Cell · doi:10.1016/0092-8674(89)90238-9 · Cited by 463
Self-citationLuster, A. D., Greenberg, S. M., & Leder, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.219 · Cited by 446
Relation of vascular proliferation to tumor growth.
Folkman, J., & Cotran, R. S. (1976) · PubMed · Cited by 411
IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.
Luster, A. D., & Leder, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.3.1057 · Cited by 407
Interleukin-8. A corneal factor that induces neovascularization.
Strieter, R. M., Kunkel, S. L., Elner, V. M., Mártonyi, C. L., Koch, A. E., Polverini, P. J., & Elner, V. M. (1992) · PubMed Central · Cited by 383
Self-citationInhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.
Smith, D. R., Polverini, P. J., Kunkel, S. L., Orringer, M. B., Whyte, R. I., Burdick, M. D., Wilke, C. A., & Strieter, R. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1409 · Cited by 373
Self-citationVan Meir, E. G., Polverini, P. J., Chazin, V. R., Su Huang, H.-J., de Tribolet, N., & Cavenee, W. K. (1994) · Nature Genetics · doi:10.1038/ng1094-171 · Cited by 307
Self-citationInterferons and other regulatory cytokines
Meager, A. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90301-3 · Cited by 304
Strieter, R. M., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., & Polverini, P. J. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1626 · Cited by 287
Self-citationKaplan, G., Luster, A. D., Hancock, G., & Cohn, Z. A. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.1098 · Cited by 266
Basics of Cutaneous Wound Repair
CLARK, R. A. F. (1993) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1993.tb00413.x · Cited by 210
Interleukln-8 stimulates angiogenesis in rats
Hu, D. E., Hori, Y., & Fan, T. P. D. (1993) · Inflammation · doi:10.1007/bf00916100 · Cited by 179
Matsuzaki, K., Yoshitake, Y., Matuo, Y., Sasaki, H., & Nishikawa, K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9911 · Cited by 164
Maione, T. E., Gray, G. S., Hunt, A. J., & Sharpe, R. J. (1991) · PubMed · Cited by 159
EPIDEMIOLOGY AND ETIOLOGY OF LUNG CANCER
Beckett, W. S. (1993) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)01144-8 · Cited by 150
Rolfe, M. W., Kunkel, S. L., Standiford, T. J., Chensue, S. W., Allen, R., Evanoff, H. L., Phan, S. H., & Strieter, R. M. (1991) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/5.5.493 · Cited by 145
Self-citationUeki, N., Nakazato, M., Ohkawa, T., Ikeda, T., Amuro, Y., Hada, T., & Higashino, K. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(92)90201-l · Cited by 142
Stimulation of neovascularization by human rheumatoid synovial tissue macrophages
Koch, A. E., Polverini, P. J., & Leibovich, S. J. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290403 · Cited by 130
Self-citationMajewski, S., Szmurło, A., Marczak, M., Jabłońska, S., & Bollag, W. B. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570115 · Cited by 121
The combination of antiagniogenic agents to inhibit primary tumor growth and metastasis
Brem, H., Gresser, I., Grosfeld, J. A., & Folkman, J. (1993) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(05)80308-2 · Cited by 110
Regression of Experimental Iris Neovascularization with Systemic Alpha-interferon
Miller, J. W., Stinson, W. G., & Folkman, J. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31712-4 · Cited by 104
Tumor Angiogenesis Correlates With Histologic Type and Metastasis in Non-Small-Cell Lung Cancer
Yuan, A., Yang, P., Yu, C., Lee, Y. C., Yao, Y., Chen, C. L., Lee, L., Kuo, S., & Luh, K. T. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.6.8520790 · Cited by 104
Symington, F. W. (1989) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12696816 · Cited by 96
IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes.
Gusella, G. L., Musso, T., Bosco, M. C., Espinoza‐Delgado, I., Matsushima, K., & Varesio, L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2725 · Cited by 94
Mette, S. A., Pilewski, J. M., Buck, C. A., et al. (1993) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/8.5.562 · Cited by 93
Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines.
Caamaño, J., Ruggeri, B., Momiki, S., Sickler, A., Zhang, S. Y., & Klein–Szanto, A. J. (1991) · PubMed Central · Cited by 81
Gattass, C. R., King, L. B., Luster, A. D., & Ashwell, J. D. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1373 · Cited by 81
Inhibition of in vitro angiogenesis by lymphotoxin and interferon-γ
Tsuruoka, N., Sugiyama, M., Tawaragi, Y., Tsujimoto, M., Nishihara, T., Goto, T., & Sato, N. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81104-5 · Cited by 80
Inhibition of wound healing in mice by local interferon alpha/beta injection.
Stout, A. J., Gresser, I., & Thompson, W. D. (1993) · Europe PMC (PubMed Central) · Cited by 62
The production of interleukin-1 receptor antagonist by human bronchogenic carcinoma.
Smith, D. R., Kunkel, S. L., Standiford, T. J., Chensue, S. W., Rolfe, M. W., Orringer, M. B., Whyte, R. I., Burdick, M. D., Danforth, J. M., & Gilbert, A. R. (1993) · PubMed Central · Cited by 39
Self-citationBoorsma, D. M., de Haan, P., Willemze, R., & Stoof, T. J. (1994) · Archives of Dermatological Research · doi:10.1007/bf00371574 · Cited by 34
Thiol-containing compounds inhibit the production of monocyte/macrophage-derived angiogenic activity
Koch, A. E., Burrows, J. C., Polverini, P. J., Cho, M., & Leibovich, S. J. (1991) · Inflammation Research · doi:10.1007/bf01988728 · Cited by 29
Self-citation
Cited by
Cancer as an overhealing wound: an old hypothesis revisited
Schäfer, M., & Werner, S. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2455 · Cited by 956
The roles of IFNγ in protection against tumor development and cancer immunoediting
Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00038-7 · Cited by 899
CXC chemokines in angiogenesis
Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., & Strieter, R. M. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.1.1 · Cited by 804
Self-citationMig and IP-10: CXC chemokines that target lymphocytes
Farber, J. M. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.3.246 · Cited by 779
Lasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., Mazzinghi, B., Orlando, C., Maggi, E., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021897 · Cited by 739
Metadata
- Authors
- Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C., Taub, D. T., Iannettoni, M. D., Whyte, R. I., & Strieter, R. M.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-09-01
- Volume
- 184
- Issue
- 3
- Pages
- 981-992
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2010003229
- Cited by
- 353
- References
- 49
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.